BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $109,131 | -3.6% | 110,000 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $113,234 | +3.7% | 110,000 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $109,241 | -24.5% | 110,000 | -18.5% | 0.00% | -50.0% |
| Q4 2022 | $144,665 | +8.0% | 135,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $134,000 | 0.0% | 135,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $134,000 | – | 135,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 52,096 | $55,672 | 3.77% |
| MACKAY SHIELDS LLC | 77,043,000 | $83,172,605 | 2.12% |
| Sonora Investment Management Group, LLC | 7,960,000 | $8,654,409 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 12,390,000 | $17,994,379 | 0.73% |
| BRAIDWELL LP | 19,200,000 | $20,727,568 | 0.70% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 32,064,000 | $34,615,044 | 0.60% |
| LOOMIS SAYLES & CO L P | 2,089,754 | $216,269 | 0.43% |
| Liberty Mutual Group Asset Management Inc. | 825,000 | $887 | 0.24% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,386,583 | 0.09% |
| THRIVENT FINANCIAL FOR LUTHERANS | 15,950,000 | $17,139 | 0.04% |